Oza A - Search Results

1

Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial.

Stark D, Nankivell M, Pujade-Lauraine E, Kristensen G, Elit L, Stockler M, Hilpert F, Cervantes A, Brown J, Lanceley A, Velikova G, Sabate E, Pfisterer J, Carey MS, Beale P, Qian W, Swart AM, Oza A, Perren T. Stark D, et al. Among authors: oza a. Lancet Oncol. 2013 Mar;14(3):236-43. doi: 10.1016/S1470-2045(12)70567-3. Epub 2013 Jan 18. Lancet Oncol. 2013. PMID: 23333117 Free PMC article. Clinical Trial.

2

Resource implications of palliative chemotherapy for ovarian cancer.

Doyle C, Stockler M, Pintilie M, Panesar P, Warde P, Sturgeon J, Oza AM. Doyle C, et al. Among authors: oza am. J Clin Oncol. 1997 Mar;15(3):1000-7. doi: 10.1200/JCO.1997.15.3.1000. J Clin Oncol. 1997. PMID: 9060539

3

Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer.

Carmichael J, Popiela T, Radstone D, Falk S, Borner M, Oza A, Skovsgaard T, Munier S, Martin C. Carmichael J, et al. Among authors: oza a. J Clin Oncol. 2002 Sep 1;20(17):3617-27. doi: 10.1200/JCO.2002.10.129. J Clin Oncol. 2002. PMID: 12202662 Clinical Trial.

4

Phase II study of CGP 69846A (ISIS 5132) in recurrent epithelial ovarian cancer: an NCIC clinical trials group study (NCIC IND.116).

Oza AM, Elit L, Swenerton K, Faught W, Ghatage P, Carey M, McIntosh L, Dorr A, Holmlund JT, Eisenhauer E; NCIC Clinical Trials Group Study (NCIC IND.116). Oza AM, et al. Gynecol Oncol. 2003 Apr;89(1):129-33. doi: 10.1016/s0090-8258(02)00144-0. Gynecol Oncol. 2003. PMID: 12694666 Clinical Trial.

5

Multicenter, randomized phase II trial of oral CI-1033 for previously treated advanced ovarian cancer.

Campos S, Hamid O, Seiden MV, Oza A, Plante M, Potkul RK, Lenehan PF, Kaldjian EP, Varterasian ML, Jordan C, Charbonneau C, Hirte H. Campos S, et al. Among authors: oza a. J Clin Oncol. 2005 Aug 20;23(24):5597-604. doi: 10.1200/JCO.2005.08.091. J Clin Oncol. 2005. PMID: 16110019 Clinical Trial.

6

Chemotherapy for recurrent, metastatic, or persistent cervical cancer: a systematic review.

Hirte HW, Strychowsky JE, Oliver T, Fung-Kee-Fung M, Elit L, Oza AM. Hirte HW, et al. Among authors: oza am. Int J Gynecol Cancer. 2007 Nov-Dec;17(6):1194-204. doi: 10.1111/j.1525-1438.2007.00900.x. Epub 2007 Jun 1. Int J Gynecol Cancer. 2007. PMID: 17540006 Review.

7

Evaluation of an intraperitoneal chemotherapy program implemented at the Princess Margaret Hospital for patients with epithelial ovarian carcinoma.

Chin SN, Pinto V, Rosen B, Oza A, Dodge J, Murphy J, Mackay H. Chin SN, et al. Among authors: oza a. Gynecol Oncol. 2009 Mar;112(3):450-4. doi: 10.1016/j.ygyno.2008.11.021. Epub 2009 Jan 10. Gynecol Oncol. 2009. PMID: 19135709 Clinical Trial.

8

Efficacy of pegylated liposomal doxorubicin (PLD) plus carboplatin in ovarian cancer patients who recur within six to twelve months: a phase II study.

Power P, Stuart G, Oza A, Provencher D, Bentley JR, Miller WH Jr, Pouliot JF. Power P, et al. Among authors: oza a. Gynecol Oncol. 2009 Sep;114(3):410-4. doi: 10.1016/j.ygyno.2009.04.037. Epub 2009 Jun 10. Gynecol Oncol. 2009. PMID: 19520420 Clinical Trial.

9

Symptom control in patients with recurrent ovarian cancer: measuring the benefit of palliative chemotherapy in women with platinum refractory/resistant ovarian cancer.

Friedlander M, Butow P, Stockler M, Gainford C, Martyn J, Oza A, Donovan HS, Miller B, King M. Friedlander M, et al. Among authors: oza a. Int J Gynecol Cancer. 2009 Dec;19 Suppl 2:S44-8. doi: 10.1111/IGC.0b013e3181bf7fb8. Int J Gynecol Cancer. 2009. PMID: 19955914 Review.

10

Temsirolimus in combination with carboplatin and paclitaxel in patients with advanced solid tumors: a NCIC-CTG, phase I, open-label dose-escalation study (IND 179).

Kollmannsberger C, Hirte H, Siu LL, Mazurka J, Chi K, Elit L, Walsh W, Sederias J, Doyle A, Eisenhauer EA, Oza AM. Kollmannsberger C, et al. Among authors: oza am. Ann Oncol. 2012 Jan;23(1):238-244. doi: 10.1093/annonc/mdr063. Epub 2011 Mar 29. Ann Oncol. 2012. PMID: 21447615 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

560 results

Search Page